Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Some women with common hair loss may develop permanent hair loss.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Some birth control pills have a higher risk of blood clots than others.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.